A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PRE-I-SPY Phase I/Ib Oncology Platform Program
- Status
- RECRUITING
- Phase
- PHASE1
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)
- Status
- TERMINATED
- Phase
- PHASE1
Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy
- Status
- RECRUITING
- Phase
- NA
Metastatic Pathologic Fractures, Short Term Results
- Status
- RECRUITING
- Phase
- N/A
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Study of ART0380 in Patients With Biologically Selected Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor
- Status
- UNKNOWN
- Phase
- NA
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Liver Embolization Approaches for Tumor Management
- Status
- RECRUITING
- Phase
- N/A
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- Status
- RECRUITING
- Phase
- PHASE2
A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3